您现在的位置: 首页   -  产品中心   -  免疫学   -   抗体
CXCR3 Recombinant Rabbit mAb (S-377-8)

CXCR3 Recombinant Rabbit mAb (S-377-8)

货号: S0B0706
价格: 600
规格: 25μl
介绍: -
其他: -
产品规格
  • 宿主来源

    Rabbit
  • 分子别名

    C-X-C chemokine receptor type 3, CXC-R3, CXCR-3, CKR-L2, G protein-coupled receptor 9, Interferon-inducible protein 10 receptor (IP-10 receptor), CD183, GPR9
  • 免疫原

    Synthetic Peptide
  • 细胞定位

    Cell membrane
  • Accession

    P49682
  • 克隆号

    S-377-8
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG
  • 应用

    IHC-P
  • 反应种属 ?

    Hu
  • 纯化方式

    Protein A
  • 浓度

    0.5 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

稀释度
应用 稀释度
IHC-P 1:2000
背景介绍
  • CXCR3, also known as C-X-C chemokine receptor type 3, is a G-protein-coupled receptor primarily expressed on the surface of activated T cells, B cells, and natural killer (NK) cells. It functions by binding to specific ligands on target cell membranes, inducing targeted migration and immune responses. CXCR3 plays a significant role in infection, autoimmune diseases, and tumor immunology. As a receptor for CXC chemokines such as CXCL9, CXCL10, and CXCL11, CXCR3 affects human mesangial cells (HMC) and other cell types through G-protein signaling. CXCR3 may also bind to CCL21, potentially contributing to chemotactic responses. Additionally, CXCR3 plays a crucial role in directing the migration of effector T cells to sites of inflammation and tumors, with its activation preferentially leading to high expression in Th1-type CD4+ T lymphocytes, effector CD8+ T lymphocytes, NK cells, and NKT cells. In recent years, numerous studies have confirmed that the expression of CXCR3 and its ligands in the body is closely related to tumor immunity, tumorigenesis, and metastasis. Therefore, CXCR3 has the potential to become a new indicator for assessing the prognosis of tumor patients and a new target for clinical tumor immunotherapy.

  • 免疫组化

    • IHC shows positive staining in paraffin-embedded human tonsil. Anti-CXCR3 antibody was used at 1/2000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded human stomach. Anti-CXCR3 antibody was used at 1/2000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded human Hodgkin’s lymphoma. Anti-CXCR3 antibody was used at 1/2000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded human cervical squamous cell carcinoma. Anti-CXCR3 antibody was used at 1/2000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded human colon cancer. Anti-CXCR3 antibody was used at 1/2000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded human pancreatic carcinoma. Anti-CXCR3 antibody was used at 1/2000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.